HIGHLIGHTS
- who: Xueying Fan from the Male, week-old BALB/c mice were purchased from the Laboratory Animal Center of Southern Medical University [SCXK(GZ)2019-0041, Guangzhou, China]They were kept in the animal laboratory at International Institute for Translational Chinese Medicine [SYXK (GZ), ]. For the xenograft mouse model have published the article: Brevilin A is a potent anti-metastatic CRC agent that targets the VEGF-IL6-STAT3 axis in the HSCs-CRC interplay, in the Journal: (JOURNAL) of 25/03/2023
- what: The findings not only support the development of as novel therapeutic agent . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.